Nobel İlaç's Deputy Chairman of the Board and Nobel AFF General Manager, Mr. Selçuk Tanrıverdi, Awarded as the CEO of the Year in Kazakhstan

Nobel İlaç's Deputy Chairman of the Board and Nobel AFF General Manager, Mr. Selçuk Tanrıverdi, Awarded as the CEO of the Year in Kazakhstan
Nobel İlaç's esteemed Deputy Chairman of the Board and Nobel AFF General Manager, Mr. Selçuk Tanrıverdi, has been recognized as the "Centras 500 CEO of the Year" in Kazakhstan.

The CEO of the Year title, a significant distinction in Kazakhstan's Centras 500 business ranking, is determined by the Kazakhstan Growth Forum, which comprises esteemed members from recognized institutions such as the Kazakhstan Economists Association, IDC, IFC, Grant Thornton, Ernst & Young, KPMG, PwC, McKinsey, and Qazaq Independent Directors. 
We are immensely proud of Mr. Selçuk Tanrıverdi's deserving recognition as the "CEO of the Year" in the influential Centras 500 business ranking.

The esteemed "Centras 500 CEO of the Year" accolade is determined by the Kazakhstan Growth Forum, which consists of prominent members from renowned institutions such as the Kazakhstan Economists Association, IDC, IFC, Grant Thornton, Ernst & Young, KPMG, PwC, McKinsey, and Qazaq Independent Directors. 
This prestigious award is a reflection of the strong leadership attributes of CEOs  and symbolizes how these leadership qualities resonate with the company's successes. 

Nobel İlaç Continues its Expansion in Kazakhstan with Nobel AFF

Nobel AFF in Kazakhstan remains one of our sources of pride on the international front. Driven by the "Health is worth it" principle, Nobel İlaç's maiden foray into the global scene transpired within the Ulkar Holding umbrella in Kazakhstan. Established in 2002, Nobel AFF was the country's inaugural foreign-capital production facility. 
As the first company to be granted a GMP certificate in Kazakhstan, Nobel AFF garners attention with its achievements in exports and its notable position in tax rankings. Nobel AFF is at the forefront of innovation and progress in the Kazakh pharmaceutical sector.


With a workforce nearing 500 individuals, Nobel AFF maintains operations with an annual production capacity of 750 million tablets, 250 million capsules, 20 million syrups and suspensions, and 10 million creams and ointments. Boasting approximately 300 distinct products in the local market, Nobel AFF further exports its range to countries including Kyrgyzstan, Uzbekistan, Russia, and Belarus. Through its high-caliber production, Nobel AFF continues to amplify its contribution to both the pharmaceutical industry in Kazakhstan and, via its exports, to the broader Kazakh economy.